EX-99.1 2 d112759dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Unaudited Pro Forma Condensed Consolidated Financial Information

On January 21, 2021, Canada’s Island Garden Inc. (“FIGR East”), FIGR Norfolk Inc. (“FIGR Norfolk”) and FIGR Brands, Inc. (“FIGR Brands”; and together with FIGR East and FIGR Norfolk, the “Canadian Cannabis Subsidiaries”), which are indirect subsidiaries of Pyxus International, Inc. (the “Company”), applied for relief from their respective creditors pursuant to Canada’s Companies’ Creditors Arrangement Act (the “CCAA”) in the Ontario Superior Court of Justice (the “Court”) in Ontario, Canada (the “CCAA Proceeding”). On January 21, 2021 (the “Order Date”), upon application by the Canadian Cannabis Subsidiaries, the Court issued an order for creditor protection of the Canadian Cannabis Subsidiaries pursuant to the provisions of the CCAA and the appointment of FTI Consulting Canada Inc. to serve as the Court-appointed monitor of the Canadian Cannabis Subsidiaries during the pendency of the CCAA Proceeding (the “Monitor”).

The Canadian Cannabis Subsidiaries collectively operate businesses for the production and sale to retailers in Canada of cannabis products under licenses issued by Health Canada. The Canadian Cannabis Subsidiaries are the only subsidiaries of the Company engaged in such business.

As a result of the commencement of the CCAA Proceeding and the appointment of the Monitor, the Company has determined that, in accordance with U.S. generally accepted accounting principles, the Canadian Cannabis Subsidiaries will be deconsolidated from the Company’s financial statements as of the Order Date.

The accompanying unaudited pro forma condensed consolidated financial information has been prepared to illustrate the effect of the deconsolidation of the Canadian Cannabis Subsidiaries on prior periods. The unaudited pro forma condensed consolidated balance sheet as of September 30, 2020 gives effect to the deconsolidation as if it occurred on September 30, 2020. The unaudited pro forma condensed consolidated statements of operations for the years ended March 31, 2020 and 2019 and for the six months ended September 30, 2020 give effect to the deconsolidation as if it had occurred on April 1, 2018.

On June 15, 2020, Old Holdco, Inc. (then named Pyxus International, Inc.) (“Old Pyxus”) and its then subsidiaries Alliance One International, LLC, Alliance One North America, LLC, Alliance One Specialty Products, LLC and GSP Properties, LLC (collectively, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) under Chapter 11 of the United States Bankruptcy Code with the Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) to implement a prepackaged Chapter 11 plan of reorganization to effectuate a financial restructuring (the “Restructuring”) of Old Pyxus’ secured debt. On August 21, 2020, the Bankruptcy Court issued an order (the “Confirmation Order”) confirming the Amended Joint Prepackaged Chapter 11 Plan of Reorganization (the “Plan”) filed by the Debtors in the Chapter 11 Cases. On August 24, 2020 (the “Effective Date”), the Plan became effective in accordance with its terms, and the Debtors emerged from the Chapter 11 Cases. In connection with the satisfaction of the conditions to effectiveness as set forth in the Confirmation Order and the Plan, Old Pyxus completed a series of transactions pursuant to which the business assets and operations of Old Pyxus were vested in a new Virginia corporation, Pyxus Holdings, Inc., which is an indirect subsidiary of the Company. Pursuant to the Confirmation Order and the Plan, at the effectiveness of the Plan all outstanding shares of common stock, and rights to acquire the common stock, of Old Pyxus were cancelled and the shares of common stock of the Company were delivered to certain creditors of Old Pyxus. As a result of these transactions, the Company is deemed to be the successor to Old Pyxus.

The Company applied Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 852 – Reorganizations (“ASC 852”) in preparing its condensed consolidated financial statements for the six-month period ended September 30, 2020. For periods subsequent to the Chapter 11 filing, ASC 852 requires distinguishing transactions associated with the reorganization separate from

activities related to the ongoing operations of the business. Upon the effectiveness of the Plan and the emergence of the Debtors from the Chapter 11 Cases, the Company determined it qualified for fresh start reporting under ASC 852, which resulted in the Company becoming a new entity for financial reporting purposes on the Effective Date. The Company elected to apply fresh start reporting using a convenience date of August 31, 2020 (the “Fresh Start Reporting Date”). Due to the application of fresh start reporting, the pre-emergence and post-emergence periods are not comparable. The lack of comparability is emphasized by the use of a “black line” to separate the Predecessor and Successor periods in the Company’s condensed consolidated financial statements for periods spanning the Fresh Start Reporting Date. References to “Successor” relate to the Company’s results of operations after August 31, 2020. References to “Predecessor” relate to the Company’s results of operations on or before August 31, 2020.

The presentation of the pro forma condensed consolidated statement of operations for the six months ended September 30, 2020 presents combined historical results, prior to any pro forma adjustments, which combined results represent the sum of the reported amounts for the Predecessor period April 1, 2020 through August 31, 2020 combined with the Successor period from September 1, 2020 through September 30, 2020.

The unaudited pro forma condensed consolidated statements of operations are based on estimates and assumptions, which have been made solely for the purposes of developing such pro forma information. The pro forma adjustments are based upon available information and certain assumptions that the Company believes are reasonable. The unaudited pro forma condensed consolidated statements of operations do not reflect certain material nonrecurring charges or credits that resulted from the deconsolidation and will be included in the Company’s income for periods following the deconsolidation. These items include direct cash expense for severance of approximately $2.7 million and non-cash impairment charges, which cannot yet be estimated.

The unaudited pro forma condensed consolidated financial information is provided for illustrative purposes only and does not purport to represent what the actual consolidated results of operations or the consolidated financial position of the Company would have been had the deconsolidation of the Canadian Cannabis Subsidiaries occurred on the dates assumed, nor are they necessarily indicative of future consolidated results of operations or financial position.

 

2

Old Holdco, Inc. (formerly Pyxus International, Inc.) and Subsidiaries

Pro Forma Condensed Consolidated Statements of Operations (Unaudited)

 

    

Year Ended
March 31,

2019

                 Year Ended
March 31,
2019		  
(in thousands)    (as reported)     Adjustments     Notes     (pro forma)  

Sales and other operating revenues

    $ 1,801,593     $ (4,718 )      (a)     $ 1,796,875  

Cost of goods and services sold

      1,550,779       (5,075 )      (a)       1,545,704  
  

 

 

    

 

 

    

 

 

    

 

 

  

Gross profit

      250,814       357         251,171  

Selling, general, and administrative expenses

      172,831       (11,813 )      (b)       161,018  

Other income, net

      14,217       321       (c)       14,538  

Restructuring and asset impairment charges

      4,946       —           4,946  
  

 

 

    

 

 

    

 

 

    

 

 

  

Operating income

      87,254       12,491         99,745  

Interest expense

      135,553       388       (d)       135,941  

Interest income and debt retirement benefit

      5,382       —           5,382  

Income tax expense

      37,840       342       (e)       38,182  

Income from unconsolidated affiliates, net

      9,589       —           9,589  

Net (loss) income attributable to noncontrolling interest

      (701 )      (725 )      (f)       24  
  

 

 

    

 

 

    

 

 

    

 

 

  

Net loss (income) from continuing operations

      70,467       (11,037 )        59,430  
  

 

 

    

 

 

    

 

 

    

 

 

  

 

(a)

This adjustment reflects the elimination of sales and other operating revenues and cost of goods and services sold of the Canadian Cannabis Subsidiaries.

(b)

This adjustment reflects the elimination of selling, general, and administrative expenses of the Canadian Cannabis Subsidiaries. Not included in the pro forma results are anticipated savings due to costs that may be reduced or eliminated.

(c)

This adjustment reflects the elimination of other income, net from the deconsolidation of the Canadian Cannabis Subsidiaries.

(d)

This adjustment reflects the impact on interest expense from the deconsolidation of the Canadian Cannabis Subsidiaries.

(e)

This adjustment reflects the elimination of income tax expense of the Canadian Cannabis Subsidiaries. Not included in the pro forma results is the revision of the effective tax rate on the pro forma results.

(f)

This adjustment reflects the elimination of (loss) income from noncontrolling interests in the Canadian Cannabis Subsidiaries.

 

3

Old Holdco, Inc. (formerly Pyxus International, Inc.) and Subsidiaries

Pro Forma Condensed Consolidated Statements of Operations (Unaudited)

 

     Year Ended
March 31,
2020		                 Year Ended
March 31,
2020		  
(in thousands)    (as reported)     Adjustments     Notes     (pro forma)  

Sales and other operating revenues

    $ 1,527,261     $ (5,189 )      (a)     $ 1,522,072  

Cost of goods and services sold

      1,302,582       (5,299 )      (a)       1,297,283  
  

 

 

    

 

 

    

 

 

    

 

 

  

Gross profit

      224,679       110         224,789  

Selling, general, and administrative expenses

      199,016       (32,536 )      (b)       166,480  

Other income, net

      2,133       905         3,038  

Restructuring and asset impairment charges

      5,646       —           5,646  

Goodwill impairment

      33,759       —           33,759  
  

 

 

    

 

 

    

 

 

    

 

 

  

Operating (loss) income

      (11,609 )      33,551         21,942  

Interest expense

      136,656       2,694       (c)       139,349  

Interest income

      3,850       5,380       (c)       9,230  

Income tax expense

      131,789       3,453       (d)       135,242  

Income from unconsolidated affiliates, net

      5,885       —           5,885  

Net loss attributable to noncontrolling interests

      5,658       1,890       (e)       3,768  
  

 

 

    

 

 

    

 

 

    

 

 

  

Net loss from continuing operations

      264,661       30,895         233,766  
  

 

 

    

 

 

    

 

 

    

 

 

  

 

(a)

This adjustment reflects the elimination of sales and other operating revenues and cost of goods and services sold of the Canadian Cannabis Subsidiaries.

(b)

This adjustment reflects the elimination of selling, general, and administrative expenses of the Canadian Cannabis Subsidiaries. Not included in the pro forma results are anticipated savings due to costs that may be reduced or eliminated.

(c)

This adjustment reflects the impact on interest expense and interest income from the deconsolidation of the Canadian Cannabis Subsidiaries.

(d)

This adjustment reflects the elimination of income tax expense of the Canadian Cannabis Subsidiaries. Not included in the pro forma results is the revision of the effective tax rate on the pro forma results.

(e)

This adjustment reflects the elimination of loss from noncontrolling interests in the Canadian Cannabis Subsidiaries.

 

4

Pyxus International, Inc. and Subsidiaries

Pro Forma Condensed Consolidated Statements of Operations (Unaudited)

 

     Successor     Predecessor        
     One Month
Ended
September 30,
2020		     Five Months
Ended
August 31,
2020		     Six Months
Ended
September 30,
2020		                Six Months
Ended
September 30,
2020		  
(in thousands)    (as reported)     (as reported)     (combined)*      Adjustments     Notes   (pro forma)  

Sales and other operating revenues

    $ 117,834     $ 447,600     $ 565,434      $ (3,126 )    (a)   $ 562,308  

Cost of goods and services sold

      107,466       402,594       510,060        (5,560 )    (a)     504,500  
  

 

 

    

 

 

    

 

 

     

 

 

    

 

  

 

 

  

Gross profit

      10,368       45,006       55,374        2,435         57,809  

Selling, general, and administrative expenses

      15,684       87,858       103,542        (9,477 )    (b)     94,065  

Other expense, net

      1,933       539       2,472        2,193     (c)     279  

Restructuring and asset impairment charges

      1,217       566       1,783        —           1,783  
  

 

 

    

 

 

    

 

 

     

 

 

    

 

  

 

 

  

Operating loss

      8,466       43,957       52,423        14,105         38,318  

Interest expense and debt retirement expense

      8,203       46,616       55,647        1,293     (d)     56,940  

Interest income

      54       1,426       1,480        5,522     (d)     7,002  

Reorganization items:

                

Fresh start reporting expenses

        91,541       91,541        23,024     (e)     68,517  

Other reorganization income

        197,525       197,525        —           197,525  

Income tax benefit (expense)

      10,583       (292 )      10,291        913     (f)     9,378  

Income from unconsolidated affiliates, net

      234       2,358       2,592        —           2,592  

Net loss attributable to noncontrolling interest

      485       962       1,447        1,050     (g)     397  
  

 

 

    

 

 

    

 

 

     

 

 

    

 

  

 

 

  

Net income (loss) from continuing operations

      (5,313 )      19,037       13,724        39,394         53,118  
  

 

 

    

 

 

    

 

 

     

 

 

    

 

  

 

 

  

 

*

The presentation of the unaudited condensed consolidated statement of operations for the six months ended September 30, 2020 presents combined historical results, prior to any pro forma adjustments, which combined results represent the sum of the reported amounts for the Predecessor period April 1, 2020 through August 31, 2020 combined with the Successor period from September 1, 2020 through September 30, 2020.

(a)

This adjustment reflects the elimination of sales and other operating revenues and cost of goods and services sold of the Canadian Cannabis Subsidiaries.

(b)

This adjustment reflects the elimination of selling, general, and administrative expenses of the Canadian Cannabis Subsidiaries. Not included in the pro forma results are anticipated savings due to costs that may be reduced or eliminated.

(c)

This adjustment reflects the elimination of other expense, net from the deconsolidation of the Canadian Cannabis Subsidiaries.

(d)

This adjustment reflects the impact on interest expense and debt retirement expense, and interest income from the deconsolidation of the Canadian Cannabis Subsidiaries.

(e)

This adjustment reflects the elimination of fresh start reporting expenses of the Canadian Cannabis Subsidiaries. Not included in the pro forma results is the impact on other fresh start reporting expenses on the pro forma results.

(f)

This adjustment reflects the elimination of income tax benefit (expense) of the Canadian Cannabis Subsidiaries. Not included in the pro forma results is the revision of the effective tax rate on the pro forma results.

(g)

This adjustment reflects the elimination of loss from noncontrolling interests in the Canadian Cannabis Subsidiaries.

 

5

Pyxus International, Inc. and Subsidiaries

Pro Forma Condensed Consolidated Balance Sheet (Unaudited)

 

     September 30,
2020		                 September 30,
2020		  
(in thousands)    (as reported)     Adjustments     Notes     (pro forma)  

Cash, cash equivalents, and restricted cash

    $ 148,836     $ (959 )      (b)     $ 147,877  

Trade receivables, net

      155,531       (332 )      (b)       155,199  

Notes receivable, related parties

      —         137,752       (a)       137,752  

Inventories, net

      844,693       (14,352 )      (b)       830,341  

Other current assets

      132,757       (2,885 )      (b)       129,872  
  

 

 

    

 

 

    

 

 

    

 

 

  

Total current assets

      1,281,817       119,224         1,401,040  

Investments in unconsolidated affiliates

      67,859       (51,496 )      (c)       16,363  

Goodwill

      54,876       (8,197 )      (b)       46,679  

Other intangible assets, net

      66,024       (15,737 )      (b)       50,287  

Right-of-use assets

      34,677       (328 )      (b)       34,349  

Property, plant, and equipment, net

      173,177       (47,720 )      (b)       125,457  

Other noncurrent assets

      59,869       —           59,869  
  

 

 

    

 

 

    

 

 

    

 

 

  

Total assets

      1,738,299       (4,255 )        1,734,044  
  

 

 

    

 

 

    

 

 

    

 

 

  

Notes payable to banks

      457,916       —           457,916  

Accounts payable

      56,850       (2,156 )      (b)       54,693  

Accrued expenses and other current liabilities

      155,283       (2,275 )      (b)       153,008  
  

 

 

    

 

 

    

 

 

    

 

 

  

Total current liabilities

      670,049       (4,432 )        665,617  

Long-term debt

      550,196       (332 )      (b)       549,864  

Pension, postretirement, and other long-term liabilities

      129,021       (1,179 )      (b)       127,842  
  

 

 

    

 

 

    

 

 

    

 

 

  

Total liabilities

      1,349,266       (5,942 )        1,343,324  

Common stock

      391,402       —           391,402  

Retained deficit

      (5,313 )      1,687       (d)       (3,626 ) 

Accumulated other comprehensive loss

      828       —           (828 ) 

Noncontrolling interests

      3,772       —           3,772  
  

 

 

    

 

 

    

 

 

    

 

 

  

Total stockholders’ equity

      389,033       1,687         390,720  
  

 

 

    

 

 

    

 

 

    

 

 

  

Total liabilities and stockholders’ equity

      1,738,299       (4,255 )        1,734,044  
  

 

 

    

 

 

    

 

 

    

 

 

  

 

(a)

This adjustment reflects the recognition of notes receivable, related parties from the Canadian Cannabis Subsidiaries.

(b)

This adjustment reflects the elimination of assets and liabilities attributable to the Canadian Cannabis Subsidiaries.

(c)

This adjustment reflects the impact to investments in unconsolidated affiliates attributable to the Canadian Cannabis Subsidiaries.

(d)

This adjustment reflects the elimination of retained earnings attributable to the Canadian Cannabis Subsidiaries.

 

6